Fingerprint
Dive into the research topics of 'Nivolumab in NSCLC: Latest evidence and clinical potential'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Nivolumab in NSCLC: Latest evidence and clinical potential
Raghav Sundar, Byoung Chul Cho, Julie R. Brahmer, Ross A. Soo
Research output: Contribution to journal › Review article › peer-review
174
Citations
(Scopus)